Analysis of the N-terminal region of the murine leukemia virus nucleocapsid protein

Virus Research

Volumn 155, Issue 1, 2011, Pages 181-188

  Still, Amelia ^b   Huseby, Douglas ^c   Barklis, Eric ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gag; Murine leukemia virus; Nucleocapsid; Retrovirus

Indexed keywords

NUCLEOCAPSID PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CROSS LINKING; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RETROVIRUS; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; CELLS, CULTURED; HUMANS; MOLONEY MURINE LEUKEMIA VIRUS; MUTAGENESIS, INSERTIONAL; NUCLEOCAPSID PROTEINS; RATS; VIRUS REPLICATION;

ALPHARETROVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MIRIDAE; MOLONEY MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS; ROUS SARCOMA VIRUS;

EID: 78650541994     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.10.001     Document Type: Article

References (31)

1. Adamson C., Ablan S., Boeras I., Goila-Guar R., Soheilian F., Nagashima K., Li F., Salzwedel K., Sakalian M., Wild C., Freed E. In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA457 (Bevirimat). J. Virol. 2006, 80:10957-10971.
2. Alfadhli A., Steel E., Finley L., Bchinger H., Barklis E. Hantavirus nucleocapsid protein coiled-coil domains. J. Biol. Chem. 2002, 277:27103-27108.
3. Berwin B., Barklis E. Retrovirus-mediated insertion of expressed and non-expressed transcription units into identical chromosomal sites. Nucleic Acids Res. 1993, 21:2399-2407.
4. Borsetti A., Ohagen A., Gottlinger H.G. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J. Virol. 1998, 72:9313-9317.
5. Cheslock S., Poon D., Fu W., Rhodes T., Henderson L., Nagashima K., McGrath C., Hu W.-S. Charged assembly helix motif in murine leukemia virus capsid: an important region for virus assembly and particle size determination. J. Virol. 2003, 77:7058-7066.
6. Coffin J., Hughes S., Varmus H. Retroviruses 1997, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
7. Craven R., Leure-duPree A., Erdie C., Wilson C., Wills J.W. Necessity of the spacer peptide between CA and NC in the Rous sarcoma virus gag protein. J. Virol. 1993, 67:6246-6252.
8. Gross I., Hohenberg H., Huckhagel C., Krausslich H.-G. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 1998, 72:4798-4810.
9. Gross I., Hohenberg H., Wilk T., Wiegers K., Grattinger M., Muller B., Fuller S., Krausslich H.-G. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 2000, 19:103-113.
10. Guo X., Liang C. Opposing effects of the M368A point mutation and deletion of the SP1 region on membrane binding of human immunodeficiency virus type 1 Gag. Virology 2005, 335:232-241.
11. Hansen M., Barklis E. Structural interactions between retroviral Gag proteins examined by cysteine crosslinking. J. Virol. 1995, 69:1150-1159.
12. Hansen M., Jelinek L., Jones R., Barklis E. Assembly and composition of intracellular particles formed by Moloney murine leukemia virus. J. Virol. 1993, 67:5163-5174.
13. Jones T., Blaug G., Hansen M., Barklis E. Assembly of gag-B galactosidase proteins into retrovirus particles. J. Virol. 1990, 64:2265-2279.
14. Keller P., Johnson M., Vogt V. Mutations in the spacer peptide and adjoining sequences in Rous Sarcoma virus Gag lead to tubular budding. J. Virol. 2008, 82:6788-6797.
15. Kempler G., Freitag B., Berwin B., Nanassy O., Barklis E. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site. Virology 1993, 193:690-699.
16. Krausslich H., Facke M., Heuser A., Konvalinka J., Zentgraf H. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J. Virol. 1995, 69:3407-3419.
17. Li F., Goila-Gaur R., Salzwedel K., Kilgore N., Reddick M., Matallana C., Castillo A., Zoumplis D., Martin D., Orenstein J., Allaway G., Freed E., Wild C. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:13555-13560.
18. Li F., Zoumplis D., Matallana C., Kilgore N., Reddick M., Yunis A., Adamson C., Salzwedel K., Martin D., Allaway G., Freed E., Wild C. Determinants of activity of the HIV-1 maturation inhibitor PA457. Virology 2006, 356:217-224.
19. McDermott J., Karanjia S., Love Z., Barklis E. Crosslink analysis of N-terminal, C-terminal, and N/B determining regions of the Moloney murine leukemia virus capsid protein. Virology 2000, 269:190-200.
20. Reik W., Weiher H., Jaenisch R. Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:1141-1145.
21. Sakalian M., McMurtey C., Deeg F., Maloy C., Li F., Wild C., Salzwedel K. 3-O(3',3'-dimethylsuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro. J. Virol. 2006, 80:5716-5722.
22. Scholz I., Arvidson B., Huseby D., Barklis E. Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain. J. Virol. 2005, 79:1470-1479.
23. Scholz I., Still A., Dhenub T., Coday K., Webb M., Barklis E. Analysis of human immunodeficiency virus matrix domain replacements. Virology 2008, 371:322-335.
24. Swanstrom R., Wills J. Synthesis, assembly and processing of viral proteins. Retroviruses 1997, 263-334. Cold Spring Harbor Laboratory Press, NY. J. Coffin, S. Hughes, H. Varmus (Eds.).
25. Wang C., Barklis E. Human immunodeficiency virus gag protein mutants defective in assembly, processing, and infectivity. J. Virol. 1993, 67:4264-4273.
26. Wang C., Stegeman-Olsen J., Zhang Y., Barklis E. Assembly of HIV Gag-B-Galactosidase fusion proteins into virus particles. Virology 1994, 200:524-534.
27. Wright E., Schooler J., Ding H.J., Kieffer C., Fillmore C., Sundquist W., Jensen G. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 2007, 26:2218-2226.
28. Zhang Y., Qian H., Love Z., Barklis E. Analysis of the assembly function of the HIV-1 nucleocapsid protein. J. Virol. 1998, 72:1782-1789.
29. Zhou J., Chen C.H., Aiken C. The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-(3'3'-dimethylsuccinyl)-betulinic acid. Retrovirology 2004, 1:15.
30. Zhou J., Yuan X., Dismuke D., Forshey B., Lundquist C., Lee K., Aiken C., Chen C. Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation. J. Virol. 2004, 78:922-929.
31. Zhou J., Huang L., Hachey D., Chen C.H., Aiken C. Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles. J. Biol. Chem. 2005, 280:42149-42155.